Quantcast
Last updated on April 23, 2014 at 17:36 EDT

US Drug Watchdog Now Calls Its Initiative for Diabetics Who Used the Diabetes Drug Actos and Then Developed Bladder Cancer Its Most Important Initiative for 2012

January 5, 2012

The US Drug Watchdog says, “The US Drug Watchdog says, “Few people would ever consider the possibility of a drug being used for diabetes, could also be related to elevated cases of bladder cancer. It is for this reason we need the help of loved ones, or family members of diabetics, who now have bladder cancer, to ask if the diabetic was, or is using the diabetes drug called Actos. There appears to be a correlation between US diabetics, bladder cancer, and the diabetes drug called Actos, and we want to identify every possible victim in the hopes we can get them the best available help. We are calling our Actos Initiative for diabetics, who used the diabetes drug called Actos, and then developed bladder cancer, one of our most important pharmaceutical initiatives in 2012. According to the AP, “The FDA has issued a warning that Actos may be linked to an increased risk of bladder cancer. Meanwhile, both Germany and France have suspended sales of Actos. The Actos suspension became effective July 11, 2011. Actos (pioglitazone), along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication.” .” They say, “We want to hear from any user of the diabetes medication called Actos, if they have developed bladder cancer. If after using Actos you, or a loved one developed bladder cancer please call our group immediately at 866-714-6466.” http://USDrugWatchdog.Com

(PRWEB) January 05, 2012

The US Drug Watchdog is now calling its initiative focused on the diabetes drug called Actos, and diabetics who used this drug, and then developed bladder cancer, one of its important initiatives ever. They say, “We want to identify every user of the diabetes drug called Actos, if they have developed bladder cancer, and we think we will need the help of family members, and loved ones to help get these victims identified. There may be a elevated incidence of bladder cancer for users of the diabetes drug called Actos, and we want to identify every US victim, in the hopes we can get them some meaningful help.” http://USDrugWatchdog.Com

Actos is a member of a class of drugs known as thiazolidinediones, which have been linked to bladder cancer. Actos side effects include increased risk of congestive heart failure, and an increased risk for bladder cancer. According to the AP, “The US FDA has also issued a warning about Actos, and bladder cancer. Both Germany and France have suspended sales of Actos. The Actos suspension is effective July 11, 2011. Actos (pioglitazone), along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication.” For more information diabetics, who used the diabetes drug called Actos, who now have bladder cancer, or their loved ones are urged to call the US Drug Watchdog anytime at 866-714-6466, or contact the group via their web site at http://USDrugWatchdog.Com

The US Drug Watchdog says, “One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug’s use. If you have a friend, or loved one, who was, or is using the diabetes drug called Actos, who has developed bladder cancer, please have them call us at 866-714-6466.” http://USDrugWatchdog.Com

Case number 11cv2406 BEN BGS in the Federal District Court San Diego, CA.

# # #

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/1/prweb9073057.htm


Source: prweb